HCV Next: HCV FORECAST 2015: New Approvals, Continued Barriers to Care

Hello folks, don't miss this months edition of "HCV Next" just published online at "Healio."

Table of Contents

2014 Drug Approvals: Where We Have Been; Where We Are Going

HCV FORECAST 2015: New Approvals, Continued Barriers to Care

5 QUESTIONS
A Conversation with Henry Masur, MD

COVER STORY

Vertical Transmission of HCV: The Next Big Treatment Frontier

EDITORIAL

Conquering New Frontiers and Leveling Playing Fields

FEATURE

A Level Playing Field: HIV/HCV Coinfection in the DAA Era

HCV RX

One-A-Day: Deconstructing the Single-Tablet Regimen for HCV Genotype 1

IN THE JOURNALS

HBV/HCV Coinfection Increased Risk for Multiple Liver Diseases, Death

Anti-HCV Prevalence Higher in MSM Injection Drug Users vs. Nonusers

Simeprevir with PEG-IFN a-2a/Ribavirin Safely Treated HCV

TREND WATCH

Class Action Suit Filed Against Gilead Regarding Sale, Pricing of Sofosbuvir

EMA Panel Recommends Approval of DAA Regimen for Patients with HCV

FDA Approves ‘3D’ Combination Treatment for HCV

FDA Requests Data on Daclatasvir in Combination with Other Agents